Barril Guillermina, Trullás Juan-Carlos, González-Parra Emilio, Moreno Asunción, Bergada Eduardo, Jofre Rosa, Martínez-Ara Jorge, de Sequera Patricia, Oliver Jesús Angel, Arrieta Javier, Miró José M
Servicio de Nefrología, Hospital Universitario La Princesa, Madrid, Spain.
Enferm Infecc Microbiol Clin. 2005 Jun-Jul;23(6):335-9. doi: 10.1157/13076172.
Patients with HIV infection and end-stage renal disease (ESRD) have improved their survival in the last few years. HIV infection is not considered a contradiction for renal transplantation, but little experience exists in renal transplantation in HIV infected individuals. There is no information about the prevalence of HIV infection in Spanish patients under renal replacement therapies (RRT).
A survey was performed in Spanish dialysis units during 2004. The objective was to study the prevalence and characteristics of HIV infection in patients under RRT in Spain. We also aimed to know how many of them met the Spanish criteria to be included on the renal transplantation waiting list.
HIV prevalence was 1.15% (95%CI 0.85-1.45) of 4,962 patients who were under RRT, mostly under hemodialysis and, less commonly, peritoneal dialysis. The most frequent risk factor for HIV infection was parenteral drug use (58%). The most common causes of ESRD were glomerulonephritis (44%). The median time under RRT was 46 months. Coinfections with hepatitis C (60%) and B (7%) were found. Thirty-four percent of patients had a history of aids-defining events. Eighty-six percent were under HAART. The median CD4 cell count was 333 cells/.l and the viral load was undetectable in 68%. Of 40 patients with a completed clinical questionnaire, 9 (22.5%) met the Spanish criteria for renal transplantation.
HIV prevalence in patients under RRT in Spain is 1.15% (0.85%-1.45%) and 22.5% percent of these patients met the Spanish criteria to be included on a renal transplantation waiting list.
在过去几年中,感染人类免疫缺陷病毒(HIV)且患有终末期肾病(ESRD)的患者生存率有所提高。HIV感染并不被视为肾移植的禁忌证,但HIV感染者接受肾移植的经验较少。目前尚无关于西班牙接受肾脏替代治疗(RRT)患者中HIV感染患病率的信息。
2004年对西班牙的透析单位进行了一项调查。目的是研究西班牙接受RRT患者中HIV感染的患病率及特征。我们还旨在了解其中有多少患者符合西班牙纳入肾移植等待名单的标准。
在4962例接受RRT的患者中,HIV患病率为1.15%(95%置信区间0.85 - 1.45),这些患者大多接受血液透析,较少接受腹膜透析。HIV感染最常见的危险因素是注射吸毒(58%)。ESRD最常见的病因是肾小球肾炎(44%)。接受RRT的中位时间为46个月。发现合并丙型肝炎(60%)和乙型肝炎(7%)感染。34%的患者有艾滋病界定事件史。86%的患者接受高效抗逆转录病毒治疗(HAART)。CD4细胞计数中位数为333个/微升,68%的患者病毒载量检测不到。在40例完成临床问卷的患者中,9例(22.5%)符合西班牙肾移植标准。
西班牙接受RRT患者中HIV患病率为1.15%(0.85% - 1.45%),其中22.5%的患者符合西班牙纳入肾移植等待名单的标准。